Akila Prashant

51 papers receiving 492 citations

Akila Prashant's Hit Papers

Multidrug-Resistant Sepsis: A Critical Healthcare Challenge 2024 · 74 citations
740+1Years since publication204060

Peers

Akila Prashant
Comparison fields: 5 of 106
  • Applied Microbiology and Biotechnology 11
  • Pharmacology 50
  • Molecular Medicine 21
  • Endocrine and Autonomic Systems 22
  • Complementary and Manual Therapy 7
Replace Carmen Pantiș with:
Carmen Pantiș Romania
Marius Rus Romania
Kathleen M. Job United States
Hossein Rafiei Canada
Yuki Enoki Japan
Jin F China
Jill Hamilton‐Reeves United States
Samir Malhotra India
Banafshe Dormanesh Iran
Mansour Siavash Iran
Akila Prashant relative to Carmen Pantiș Romania Carmen Pantiș's profile →
Citations per field
00.5×10×16×
Carmen Pantiș · 1×
Citations per year

Countries citing papers authored by Akila Prashant

Since Specialization
Citations

This map shows the geographic impact of Akila Prashant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akila Prashant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akila Prashant more than expected).

Fields of papers citing papers by Akila Prashant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akila Prashant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akila Prashant. The network helps show where Akila Prashant may publish in the future.

Co-authors

The 25 scholars most cited alongside Akila Prashant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akila Prashant Line = papers co-authored together Akila Prashant links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multidrug-Resistant Sepsis: A Critical Healthcare Challenge
Hit paper breakdown →
202474
2 201366
3 201746
4 202333
5 202233
6 202127
7 201217
8 201515
9 201114
10 202413
11
Quantitation of Vascular Endothelial Growth Factor and Interleukin-6 in Different Stages of Breast Cancer.
201712
12 201812
13 201211
14
Fifty Percent Ethanolic Extract of Momordica charantia Inhibits Adipogenesis and Promotes Adipolysis in 3T3-L1 Pre-Adipocyte Cells.
201710
15 20189
16 20228
17 20088
18 20247
19 20237
20 20147

About Akila Prashant

Akila Prashant is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Endocrinology, Diabetes and Metabolism, Genetics and Epidemiology, having authored 65 papers that have together received 519 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Biomedical and Engineering Education (4 papers), Innovations in Medical Education (4 papers), Iron Metabolism and Disorders (3 papers), Hormonal and reproductive studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (11 citations), Pharmacology (50 citations), Molecular Medicine (21 citations), Endocrine and Autonomic Systems (22 citations) and Complementary and Manual Therapy (7 citations). Akila Prashant has collaborated with scholars based in India, United States and Pakistan. Frequent co-authors include Swetha Nagarahalli Kempegowda, Praveen Kulkarni, Chandini Rangaswamy, SubbaRao V. Madhunapantula, Divya P. Kumar, Kuzhuvelil B. Harikumar, Thuppil Venkatesh, Bojan Nataraj, Vivian D’Souza and Devananda Devegowda. Their work appears in journals such as Frontiers in Pharmacology, Antibiotics, Molecular Biology Reports, Frontiers in Oncology and Microbial Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact